Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1037858

	registered interest
	date	08/01/2019
	answering body	Department for Environment, Food and Rural Affairs
	answering dept id	13
	answering dept short name	Environment, Food and Rural Affairs
	answering dept sort name	Environment, Food and Rural Affairs
	hansard heading	Bovine Tuberculosis: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Environment, Food and Rural Affairs, what plans his Department has to expand the badger vaccination programme.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	206347
	answer	answer is ministerial correction date of answer 15/01/2019 answer text <p>Landowners and private groups across England can apply to Natural England for a licence to vaccinate badgers against TB. Animal &amp; Plant Health Agency (APHA) provides training for those who wish undertake such vaccination and Defra provides financial support for projects within the Edge Area under the Badger Edge Vaccination Scheme (BEVS).</p><p>BEVS, relaunched in 2018 following a global vaccine shortage, provides matched funding and training for groups that want to take part. Three groups were successful with their applications in 2018. On 13 September 2018 we re-opened the scheme and asked for expressions of interest from those wishing to apply to vaccinate from 2019. The application process closes on 25 January 2019.</p><p>A long-standing research programme at APHA to identify an oral vaccine and a palatable bait in which to deliver it is also ongoing. An efficacy study is currently in progress, with results due later this year.</p><p>We are currently considering the report of the TB Strategy review, conducted by a team led by Professor Sir Charles Godfray, the scope of which includes badger vaccination. A Government response to the review will be published later this year.</p><p> </p> answering member constituency Camborne and Redruth answering member printed George Eustice question first answered 15/01/2019 13:42:08 answering member 3934 label Biography information for George Eustice
	tabling member	4079 label Biography information for Julian Sturdy

1037847

	registered interest
	date	08/01/2019
	answering body	Department for Environment, Food and Rural Affairs
	answering dept id	13
	answering dept short name	Environment, Food and Rural Affairs
	answering dept sort name	Environment, Food and Rural Affairs
	hansard heading	Bovine Tuberculosis: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Environment, Food and Rural Affairs, how many badgers were vaccinated for TB in the last year for which information is available.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	206346
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>Provisional figures for 2017 show 327 badgers were vaccinated under licence from Natural England. The number of BCG doses made available for badger vaccination was limited in 2017 due to a global shortage and the need to prioritise supplies for human vaccination. Global BCG vaccine supply is now improving and although complete figures for the number of badgers vaccinated in 2018 are not yet available, provisional data returned to date indicate that the number will be higher than in 2017.</p><p> </p> answering member constituency Camborne and Redruth answering member printed George Eustice question first answered 16/01/2019 17:16:06 answering member 3934 label Biography information for George Eustice
	tabling member	4079 label Biography information for Julian Sturdy

1038008

	registered interest
	date	08/01/2019
	answering body	Ministry of Justice
	answering dept id	54
	answering dept short name	Justice
	answering dept sort name	Justice
	hansard heading	Prisoners' Release
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Justice, how many prisoners released on licence have been found in breach of their licence conditions and (a) recalled to custody and (b) not recalled to custody in each of the last five years.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206339
	answer	answer is ministerial correction date of answer 15/01/2019 answer text <p>(a) The number of recalls to custody following breach of licence in each of the last five years<sup>1</sup>:</p><p> </p><table><tbody><tr><td><p><strong>2013</strong></p></td><td><p><strong>2014</strong></p></td><td><p><strong>2015</strong></p></td><td><p><strong>2016</strong></p></td><td><p><strong>2017</strong></p></td></tr><tr><td><p>17330</p></td><td><p>17657</p></td><td><p>21467</p></td><td><p>21559</p></td><td><p>21914</p></td></tr></tbody></table><p> </p><p>1 The figures provided are for women and men recalled in each full year from 2013 to 2017 and may include offenders recalled more than once across multiple years or within years. The figures in these tables have been drawn from administrative IT systems, which, as with any large-scale recording system, are subject to possible errors with data entry and processing.</p><p> </p><p>The last full year available is 2017. Published statistics, including figures up to and including June 2018 are available here <a href="https://www.gov.uk/government/collections/offender-management-statistics-quarterly" target="_blank">https://www.gov.uk/government/collections/offender-management-statistics-quarterly</a></p><p>(b) We do not hold information centrally about the number of offenders in the community who may have breached their licence conditions and are not recalled to custody. To extract this data would require a review of each separate case file to track their progress on licence.</p><p>Public protection is our priority and recall is used to ensure that offenders on licence who present a high risk of harm to the public or are at risk of re-offending are returned to custody as quickly as possible.</p><p> </p><p>Offenders on licence are subject to strict licence conditions, which are designed to enable the Probation Service to manage the risk that offenders may pose on release from prison and to safeguard public protection. All offenders on licensed supervision in the community are liable to recall to prison if they fail to comply with the conditions of their licence.</p> answering member constituency Penrith and The Border answering member printed Rory Stewart question first answered 15/01/2019 17:46:13 answering member 4137 label Biography information for Rory Stewart
	tabling member	4066 label Biography information for Priti Patel

1038013

	registered interest
	date	08/01/2019
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	A12
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Transport, what assessment he has made of the potential merits of widening the A12 north of Marks Tey.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206343
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>As part of the current Road Investment Strategy, Highways England are developing a scheme to widen the A12 between Junctions 25 and 29. This will be considered against other strategic road priorities in the area as the Department make investment decisions. The Government expects to publish the second Road Investment Strategy in late 2019.</p> answering member constituency Hereford and South Herefordshire answering member printed Jesse Norman question first answered 16/01/2019 11:11:08 answering member 3991 label Biography information for Jesse Norman
	tabling member	4066 label Biography information for Priti Patel

1037959

	registered interest
	date	08/01/2019
	answering body	Home Office
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	hansard heading	Immigration Controls: Offenders
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for the Home Department, what estimate his Department has made of the number of foreign national offenders from an EU-27 member state have been prevented from entering the UK in each of the last five years.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206314
	answer	answer is ministerial correction date of answer 29/01/2019 answer text <p>Border Force prevents travel of known terrorists and serious criminals prior to their arrival in the UK with the use of API and PNR data received from carriers. Through advanced analysis of data and intelligence Border Force devises electronic rules to target persons of interest that can be shared with Border 5 partners and other government departments overseas, to secure borders not only in the country of potential risk, but globally to mitigate any threat.</p><p><br>One of Border Force’s priorities is the management of the Pre-Departure Checks Scheme (PDCS) which is designed to deny boarding to high risk in-dividuals identified by the Security Services and Home Office Special Cases Directorate.</p><p><br>The Authority to Carry Scheme has been in operation since 2015; this ena-bles Border Force to offload a passenger pre-departure, including those passengers that have Exclusion Orders, Deportation Orders or travelling on an invalid document.</p> answering member constituency Romsey and Southampton North answering member printed Caroline Nokes question first answered 29/01/2019 15:44:51 answering member 4048 label Biography information for Caroline Nokes
	tabling member	4066 label Biography information for Priti Patel

1037988

	registered interest
	date	08/01/2019
	answering body	Department for International Trade
	answering dept id	202
	answering dept short name	International Trade
	answering dept sort name	International Trade
	hansard heading	Trade Agreements
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for International Trade, what assessment he has made of the potential effect on future trade agreements and negotiations between the UK and non-EU countries caused by the UK remaining bound by the requirements of the EU's common commercial policy.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206328
	answer	answer is ministerial correction date of answer 15/01/2019 answer text <p>EU law (including the Common Commercial Policy) will apply in the UK during the Implementation Period. We have agreed with the EU that we will be able to negotiate, sign and ratify new trade deals during the Implementation Period.</p><p> </p><p>As recognised in the Political Declaration, the UK’s future relationship with the EU will need to recognise the development of an independent UK trade policy.</p> answering member constituency Meon Valley answering member printed George Hollingbery question first answered 15/01/2019 13:45:33 answering member 4016 label Biography information for Sir George Hollingbery
	tabling member	4066 label Biography information for Priti Patel

1037967

	registered interest
	date	08/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	CJD
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve diagnosis rates of sporadic Creutzfeldt-Jakob disease.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206318
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>Early diagnosis of sporadic Creutzfeldt-Jakob Disease (sCJD) is challenging as the disorder is rare, and symptoms are non-specific, mimicking those seen in more common neurodegenerative, neuroinflammatory, and infectious disorders. Rapidity of progression and lack of response to treatment often leads clinicians to suspect a CJD diagnosis.</p><p> </p><p>The Department and the Scottish Government fund the National CJD Research and Surveillance Unit (NCJDRSU) to provide inter-disciplinary clinical and laboratory expertise (neurology, neuroradiology, neuropathology, biochemistry, and epidemiology) enabling early and accurate diagnosis of CJD. Clinicians from across the United Kingdom can discuss cases at any time. Highly trained specialists assess suspected cases locally within five days of referral and conduct structured assessments (clinical history, examination, and review of investigation results) before establishing diagnoses based on validated criteria. A consultant neuroradiologist at the NCJDRSU assesses neuroimaging for patients throughout the UK with a suspicion of CJD. The unit also provides a national diagnostic cerebrospinal fluid (CSF) 14-3-3/RT-QuIC service and will arrange collection of CSF samples with prompt results. Information on how clinicians can refer cases to the NCJDRSU is available at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/referral-system" target="_blank">http://www.cjd.ed.ac.uk/surveillance/referral-system</a></p><p> </p><p>The Department and the Scottish Government have funded the development of diagnostic tests that combined with improved interpretation of neuroimaging has improved diagnostic accuracy.</p><p> </p><p>The NCJDRSU collects data on the number of people diagnosed with sCJD in the UK; break downs by of data for smaller geographies are not published. The following table shows a breakdown of the number of individuals, by year of death between 2014 and 2017. Date of diagnosis are considered synonymous for the purpose of reporting.</p><p> </p><p>Number of sCJD 2014-18 in the UK by year of death (as at January 2019).</p><table><tbody><tr><td><p>Year of death</p></td><td><p>Number</p></td></tr><tr><td><p>2014</p></td><td><p>99</p></td></tr><tr><td><p>2015</p></td><td><p>105</p></td></tr><tr><td><p>2016</p></td><td><p>119</p></td></tr><tr><td><p>2017</p></td><td><p>120</p></td></tr><tr><td><p>2018</p></td><td><p>125</p></td></tr></tbody></table><p>Source: NCJDRSU: <a href="https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf" target="_blank">https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf </a></p><p> </p><p>The NCJDRSU presents data regularly at clinical meetings and publishes in peer reviewed medical journals accessed by medical professionals, as well as producing a detailed annual report at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf" target="_blank">http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf</a></p><p> </p><p>The NCJDRSU website also provides information on the different types of CJD at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing" target="_blank">http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing</a></p><p> </p><p>sCJD is a rapidly progressive neurological disorder with an average time from first symptom onset to death of four months. The majority (88%) of individuals with sCJD over the past five years were assessed by clinicians from the NCJDRSU in life. After formal referral to NCJDRSU the average time to confirmation of the diagnosis was three days.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 206320 206323 206326 206327 question first answered 16/01/2019 15:05:48 answering member 4067 label Biography information for Steve Brine
	tabling member	4066 label Biography information for Priti Patel

1037969

	registered interest
	date	08/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	CJD
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the symptoms of sporadic Creutzfeldt-Jakob disease are identified at the earliest opportunity.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206320
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>Early diagnosis of sporadic Creutzfeldt-Jakob Disease (sCJD) is challenging as the disorder is rare, and symptoms are non-specific, mimicking those seen in more common neurodegenerative, neuroinflammatory, and infectious disorders. Rapidity of progression and lack of response to treatment often leads clinicians to suspect a CJD diagnosis.</p><p> </p><p>The Department and the Scottish Government fund the National CJD Research and Surveillance Unit (NCJDRSU) to provide inter-disciplinary clinical and laboratory expertise (neurology, neuroradiology, neuropathology, biochemistry, and epidemiology) enabling early and accurate diagnosis of CJD. Clinicians from across the United Kingdom can discuss cases at any time. Highly trained specialists assess suspected cases locally within five days of referral and conduct structured assessments (clinical history, examination, and review of investigation results) before establishing diagnoses based on validated criteria. A consultant neuroradiologist at the NCJDRSU assesses neuroimaging for patients throughout the UK with a suspicion of CJD. The unit also provides a national diagnostic cerebrospinal fluid (CSF) 14-3-3/RT-QuIC service and will arrange collection of CSF samples with prompt results. Information on how clinicians can refer cases to the NCJDRSU is available at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/referral-system" target="_blank">http://www.cjd.ed.ac.uk/surveillance/referral-system</a></p><p> </p><p>The Department and the Scottish Government have funded the development of diagnostic tests that combined with improved interpretation of neuroimaging has improved diagnostic accuracy.</p><p> </p><p>The NCJDRSU collects data on the number of people diagnosed with sCJD in the UK; break downs by of data for smaller geographies are not published. The following table shows a breakdown of the number of individuals, by year of death between 2014 and 2017. Date of diagnosis are considered synonymous for the purpose of reporting.</p><p> </p><p>Number of sCJD 2014-18 in the UK by year of death (as at January 2019).</p><table><tbody><tr><td><p>Year of death</p></td><td><p>Number</p></td></tr><tr><td><p>2014</p></td><td><p>99</p></td></tr><tr><td><p>2015</p></td><td><p>105</p></td></tr><tr><td><p>2016</p></td><td><p>119</p></td></tr><tr><td><p>2017</p></td><td><p>120</p></td></tr><tr><td><p>2018</p></td><td><p>125</p></td></tr></tbody></table><p>Source: NCJDRSU: <a href="https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf" target="_blank">https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf </a></p><p> </p><p>The NCJDRSU presents data regularly at clinical meetings and publishes in peer reviewed medical journals accessed by medical professionals, as well as producing a detailed annual report at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf" target="_blank">http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf</a></p><p> </p><p>The NCJDRSU website also provides information on the different types of CJD at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing" target="_blank">http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing</a></p><p> </p><p>sCJD is a rapidly progressive neurological disorder with an average time from first symptom onset to death of four months. The majority (88%) of individuals with sCJD over the past five years were assessed by clinicians from the NCJDRSU in life. After formal referral to NCJDRSU the average time to confirmation of the diagnosis was three days.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 206318 206323 206326 206327 question first answered 16/01/2019 15:05:48 answering member 4067 label Biography information for Steve Brine
	tabling member	4066 label Biography information for Priti Patel

1037974

	registered interest
	date	08/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	CJD
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people were diagnosed with sporadic Creutzfeldt-Jakob Disease in (a) Witham constituency, (b) the East of England and (c) England and Wales in the most recent five years for which data is available.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206323
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>Early diagnosis of sporadic Creutzfeldt-Jakob Disease (sCJD) is challenging as the disorder is rare, and symptoms are non-specific, mimicking those seen in more common neurodegenerative, neuroinflammatory, and infectious disorders. Rapidity of progression and lack of response to treatment often leads clinicians to suspect a CJD diagnosis.</p><p> </p><p>The Department and the Scottish Government fund the National CJD Research and Surveillance Unit (NCJDRSU) to provide inter-disciplinary clinical and laboratory expertise (neurology, neuroradiology, neuropathology, biochemistry, and epidemiology) enabling early and accurate diagnosis of CJD. Clinicians from across the United Kingdom can discuss cases at any time. Highly trained specialists assess suspected cases locally within five days of referral and conduct structured assessments (clinical history, examination, and review of investigation results) before establishing diagnoses based on validated criteria. A consultant neuroradiologist at the NCJDRSU assesses neuroimaging for patients throughout the UK with a suspicion of CJD. The unit also provides a national diagnostic cerebrospinal fluid (CSF) 14-3-3/RT-QuIC service and will arrange collection of CSF samples with prompt results. Information on how clinicians can refer cases to the NCJDRSU is available at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/referral-system" target="_blank">http://www.cjd.ed.ac.uk/surveillance/referral-system</a></p><p> </p><p>The Department and the Scottish Government have funded the development of diagnostic tests that combined with improved interpretation of neuroimaging has improved diagnostic accuracy.</p><p> </p><p>The NCJDRSU collects data on the number of people diagnosed with sCJD in the UK; break downs by of data for smaller geographies are not published. The following table shows a breakdown of the number of individuals, by year of death between 2014 and 2017. Date of diagnosis are considered synonymous for the purpose of reporting.</p><p> </p><p>Number of sCJD 2014-18 in the UK by year of death (as at January 2019).</p><table><tbody><tr><td><p>Year of death</p></td><td><p>Number</p></td></tr><tr><td><p>2014</p></td><td><p>99</p></td></tr><tr><td><p>2015</p></td><td><p>105</p></td></tr><tr><td><p>2016</p></td><td><p>119</p></td></tr><tr><td><p>2017</p></td><td><p>120</p></td></tr><tr><td><p>2018</p></td><td><p>125</p></td></tr></tbody></table><p>Source: NCJDRSU: <a href="https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf" target="_blank">https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf </a></p><p> </p><p>The NCJDRSU presents data regularly at clinical meetings and publishes in peer reviewed medical journals accessed by medical professionals, as well as producing a detailed annual report at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf" target="_blank">http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf</a></p><p> </p><p>The NCJDRSU website also provides information on the different types of CJD at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing" target="_blank">http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing</a></p><p> </p><p>sCJD is a rapidly progressive neurological disorder with an average time from first symptom onset to death of four months. The majority (88%) of individuals with sCJD over the past five years were assessed by clinicians from the NCJDRSU in life. After formal referral to NCJDRSU the average time to confirmation of the diagnosis was three days.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 206318 206320 206326 206327 question first answered 16/01/2019 15:05:48 answering member 4067 label Biography information for Steve Brine
	tabling member	4066 label Biography information for Priti Patel

1037977

	registered interest
	date	08/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	CJD
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to raise awareness among medical professionals of the symptoms of (a) sporadic, (b) variant, (c) genetic and (d) Iatrogenic Creutzfeldt-Jakob Disease.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206326
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>Early diagnosis of sporadic Creutzfeldt-Jakob Disease (sCJD) is challenging as the disorder is rare, and symptoms are non-specific, mimicking those seen in more common neurodegenerative, neuroinflammatory, and infectious disorders. Rapidity of progression and lack of response to treatment often leads clinicians to suspect a CJD diagnosis.</p><p> </p><p>The Department and the Scottish Government fund the National CJD Research and Surveillance Unit (NCJDRSU) to provide inter-disciplinary clinical and laboratory expertise (neurology, neuroradiology, neuropathology, biochemistry, and epidemiology) enabling early and accurate diagnosis of CJD. Clinicians from across the United Kingdom can discuss cases at any time. Highly trained specialists assess suspected cases locally within five days of referral and conduct structured assessments (clinical history, examination, and review of investigation results) before establishing diagnoses based on validated criteria. A consultant neuroradiologist at the NCJDRSU assesses neuroimaging for patients throughout the UK with a suspicion of CJD. The unit also provides a national diagnostic cerebrospinal fluid (CSF) 14-3-3/RT-QuIC service and will arrange collection of CSF samples with prompt results. Information on how clinicians can refer cases to the NCJDRSU is available at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/referral-system" target="_blank">http://www.cjd.ed.ac.uk/surveillance/referral-system</a></p><p> </p><p>The Department and the Scottish Government have funded the development of diagnostic tests that combined with improved interpretation of neuroimaging has improved diagnostic accuracy.</p><p> </p><p>The NCJDRSU collects data on the number of people diagnosed with sCJD in the UK; break downs by of data for smaller geographies are not published. The following table shows a breakdown of the number of individuals, by year of death between 2014 and 2017. Date of diagnosis are considered synonymous for the purpose of reporting.</p><p> </p><p>Number of sCJD 2014-18 in the UK by year of death (as at January 2019).</p><table><tbody><tr><td><p>Year of death</p></td><td><p>Number</p></td></tr><tr><td><p>2014</p></td><td><p>99</p></td></tr><tr><td><p>2015</p></td><td><p>105</p></td></tr><tr><td><p>2016</p></td><td><p>119</p></td></tr><tr><td><p>2017</p></td><td><p>120</p></td></tr><tr><td><p>2018</p></td><td><p>125</p></td></tr></tbody></table><p>Source: NCJDRSU: <a href="https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf" target="_blank">https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf </a></p><p> </p><p>The NCJDRSU presents data regularly at clinical meetings and publishes in peer reviewed medical journals accessed by medical professionals, as well as producing a detailed annual report at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf" target="_blank">http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf</a></p><p> </p><p>The NCJDRSU website also provides information on the different types of CJD at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing" target="_blank">http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing</a></p><p> </p><p>sCJD is a rapidly progressive neurological disorder with an average time from first symptom onset to death of four months. The majority (88%) of individuals with sCJD over the past five years were assessed by clinicians from the NCJDRSU in life. After formal referral to NCJDRSU the average time to confirmation of the diagnosis was three days.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 206318 206320 206323 206327 question first answered 16/01/2019 15:05:48 answering member 4067 label Biography information for Steve Brine
	tabling member	4066 label Biography information for Priti Patel